COLL Collegium Pharmaceutical Inc

Price (delayed)

$34.84

Market cap

$1.11B

P/E Ratio

24.36

Dividend/share

N/A

EPS

$1.43

Enterprise value

$1.55B

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium's headquarters are located in Stoughton, Massachusetts.

Highlights
Collegium Pharmaceutical's gross profit has surged by 56% YoY and by 16% QoQ
The quick ratio rose by 29% year-on-year

Key stats

What are the main financial stats of COLL
Market
Shares outstanding
31.96M
Market cap
$1.11B
Enterprise value
$1.55B
Valuations
Price to book (P/B)
5.81
Price to sales (P/S)
2.07
EV/EBIT
9.73
EV/EBITDA
5.02
EV/Sales
2.73
Earnings
Revenue
$566.77M
EBIT
$159.07M
EBITDA
$308.33M
Free cash flow
$274.29M
Per share
EPS
$1.43
Free cash flow per share
$8.13
Book value per share
$5.99
Revenue per share
$16.8
TBVPS
$17.42
Balance sheet
Total assets
$1.14B
Total liabilities
$947.88M
Debt
$674.28M
Equity
$195.43M
Working capital
$79.69M
Liquidity
Debt to equity
3.45
Current ratio
1.17
Quick ratio
1.07
Net debt/EBITDA
1.41
Margins
EBITDA margin
54.4%
Gross margin
57.5%
Net margin
8.5%
Operating margin
29.5%
Efficiency
Return on assets
4.1%
Return on equity
25.5%
Return on invested capital
26%
Return on capital employed
23.2%
Return on sales
28.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

COLL stock price

How has the Collegium Pharmaceutical stock price performed over time
Intraday
0.2%
1 week
-2.44%
1 month
-8.22%
1 year
52.27%
YTD
13.19%
QTD
-10.25%

Financial performance

How have Collegium Pharmaceutical's revenue and profit performed over time
Revenue
$566.77M
Gross profit
$326.17M
Operating income
$166.96M
Net income
$48.16M
Gross margin
57.5%
Net margin
8.5%
Collegium Pharmaceutical's gross profit has surged by 56% YoY and by 16% QoQ
Collegium Pharmaceutical's operating income has increased by 43% QoQ
Collegium Pharmaceutical's operating margin has increased by 38% QoQ
The gross margin rose by 27% year-on-year and by 12% since the previous quarter

Growth

What is Collegium Pharmaceutical's growth rate over time

Valuation

What is Collegium Pharmaceutical stock price valuation
P/E
24.36
P/B
5.81
P/S
2.07
EV/EBIT
9.73
EV/EBITDA
5.02
EV/Sales
2.73
The price to book (P/B) is 42% higher than the 5-year quarterly average of 4.1 and 32% higher than the last 4 quarters average of 4.4
The equity is up by 9% since the previous quarter
COLL's price to sales (P/S) is 38% higher than its last 4 quarters average of 1.5 and 9% higher than its 5-year quarterly average of 1.9
The revenue is up by 22% year-on-year and by 3.7% since the previous quarter

Efficiency

How efficient is Collegium Pharmaceutical business performance
The ROIC has soared by 51% from the previous quarter
Collegium Pharmaceutical's ROS has increased by 45% from the previous quarter

Dividends

What is COLL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for COLL.

Financial health

How did Collegium Pharmaceutical financials performed over time
Collegium Pharmaceutical's total assets is 21% more than its total liabilities
The quick ratio rose by 29% year-on-year
The current ratio has increased by 21% year-on-year
The debt to equity fell by 14% QoQ and by 5% YoY
The equity is up by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.